409 related articles for article (PubMed ID: 30465391)
1. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
[TBL] [Abstract][Full Text] [Related]
2. Imiglucerase treatment in Gaucher's disease.
Shah U; Nadeem N; Husen Y; Fadoo Z
J Ayub Med Coll Abbottabad; 2007; 19(2):56-9. PubMed ID: 18183722
[TBL] [Abstract][Full Text] [Related]
3. Gaucher's disease in Lithuania: its diagnosis and treatment.
Kleinotienė G; Tylki-Szymanska A; Czartoryska B
Medicina (Kaunas); 2011; 47(7):405-11. PubMed ID: 22112991
[TBL] [Abstract][Full Text] [Related]
4. Imiglucerase and its use for the treatment of Gaucher's disease.
Weinreb NJ
Expert Opin Pharmacother; 2008 Aug; 9(11):1987-2000. PubMed ID: 18627336
[TBL] [Abstract][Full Text] [Related]
5. Gaucher's disease: a review.
Morales LE
Ann Pharmacother; 1996 Apr; 30(4):381-8. PubMed ID: 8729893
[TBL] [Abstract][Full Text] [Related]
6. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
[TBL] [Abstract][Full Text] [Related]
7. [Clinical outcomes of 2 pediatric patients with Gaucher's disease in enzyme replacement therapy for 9 years].
Quijada Fraile P; Martín Hernández E; Teresa García-Silva M
Med Clin (Barc); 2011 Sep; 137 Suppl 1():43-5. PubMed ID: 22230125
[TBL] [Abstract][Full Text] [Related]
8. [Course of a case of Gaucher's disease type 1 treated over a year with glucocerebrosidase (Cérédase)].
Belmatoug N; Azorin M; Huten D; de Villemeur TB; Carbon C
Rev Med Interne; 1993; 14(10):996. PubMed ID: 8009089
[TBL] [Abstract][Full Text] [Related]
9. The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement.
Cox TM; Aerts JM; Andria G; Beck M; Belmatoug N; Bembi B; Chertkoff R; Vom Dahl S; Elstein D; Erikson A; Giralt M; Heitner R; Hollak C; Hrebicek M; Lewis S; Mehta A; Pastores GM; Rolfs A; Miranda MC; Zimran A;
J Inherit Metab Dis; 2003; 26(6):513-26. PubMed ID: 14605497
[TBL] [Abstract][Full Text] [Related]
10. [Safety of use of velaglucerase in 2 patients with type 1 Gaucher's disease].
Latre P; Giraldo P
Med Clin (Barc); 2011 Sep; 137 Suppl 1():39-42. PubMed ID: 22230124
[TBL] [Abstract][Full Text] [Related]
11. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
[TBL] [Abstract][Full Text] [Related]
12. Alglucerase. A review of its therapeutic use in Gaucher's disease.
Whittington R; Goa KL
Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912
[TBL] [Abstract][Full Text] [Related]
13. Initiation of enzyme replacement therapy for an adult patient with asymptomatic type 1 Gaucher's disease.
Tanaka N; Saito H; Ito T; Momose K; Ishida F; Hora K; Kiyosawa K; Ida H
Intern Med; 2001 Aug; 40(8):716-21. PubMed ID: 11518109
[TBL] [Abstract][Full Text] [Related]
14. [Gaucher's disease--ocular manifestation and treatment].
Filipek E; Koraszewska-Matuszewska B
Klin Oczna; 2006; 108(7-9):357-60. PubMed ID: 17290842
[TBL] [Abstract][Full Text] [Related]
15. Enzyme replacement therapy for Gaucher's disease.
Beutler E
Baillieres Clin Haematol; 1997 Dec; 10(4):751-63. PubMed ID: 9497862
[TBL] [Abstract][Full Text] [Related]
16. Neurological features in Gaucher's disease during enzyme replacement therapy.
Ono H; Fujiwara M; Ito K; Ueda H; Mizoguchi N; Sakura N
Acta Paediatr; 2001 Feb; 90(2):229-31. PubMed ID: 11236058
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic targets in Gaucher's disease].
Giraldo P; Roca M
Med Clin (Barc); 2011 Sep; 137 Suppl 1():46-9. PubMed ID: 22230126
[TBL] [Abstract][Full Text] [Related]
18. [Gaucher's disease - an overview about a sphingolipidosis].
Tamò R; Hochuli M; Beuschlein F; Nowak A
Ther Umsch; 2018 Nov; 75(4):209-214. PubMed ID: 30468119
[TBL] [Abstract][Full Text] [Related]
19. First long-term results of imiglucerase therapy of type 1 Gaucher disease.
Niederau C; vom Dahl S; Häussinger D
Eur J Med Res; 1998 Feb; 3(1-2):25-30. PubMed ID: 9512964
[TBL] [Abstract][Full Text] [Related]
20. [French results of enzyme replacement therapy in Gaucher's disease].
Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
